Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 460.00
Bid: 456.00
Ask: 464.00
Change: 0.00 (0.00%)
Spread: 8.00 (1.754%)
Open: 460.00
High: 463.00
Low: 460.00
Prev. Close: 460.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Science Group plc

13 Aug 2021 10:58

RNS Number : 6095I
Science Group PLC
13 August 2021
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Science Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Science Group plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

12 August 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, TP Group plc

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

1p Ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

0

Nil

0

(2) Cash-settled derivatives:

 

Nil

0

Nil

0

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

0

Nil

0

 

TOTAL:

Nil

0

Nil

0

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

a) Ordinary Shares of 1 pence each held by directors of Science Group plc:

 

Director

Role

Science Group Ordinary Shares

% of Science Group issued share capital

Martyn Ratcliffe

Chairman & CEO

11,412,080

27.67%

Daniel Edwards

Group Managing Director

109,000

0.26%

Peter Bertram

Independent Non-Executive Director

5,000

0.01%

 

b) Science Group plc 2021 Performance Share Plan ('PSP') granted to directors of Science Group plc:

 

Director

Maximum number of ordinary shares awarded

Date of grant

Exercise price

Exercise period

Jon Brett

10,000

7 October 2020

1 pence

7 October 2023 - 7 October 2030

Daniel Edwards

250,000

14 May 2018

1 pence

14 May 2023 - 14 May 2028

Daniel Edwards

125,000

1 October 2019

1 pence

1 October 2022 - 1 October 2029

Daniel Edwards

40,000

7 October 2020

1 pence

7 October 2023 - 7 October 2030

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

13 August 2021

Contact name:

Sarah Cole

 

Group Legal Counsel & Company Secretary

 

Telephone number:

01223 875 200

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEEANPDFLEFEEA
Date   Source Headline
28th Sep 20117:00 amRNSDirectorate Change
21st Sep 20117:00 amRNSChange of Adviser
25th Jul 20117:00 amRNSInterim Results
7th Jul 20117:00 amRNSTrading Update
16th May 201110:15 amRNSResult of AGM
16th May 20117:00 amRNSAGM Trading Update
20th Apr 201111:09 amRNSPosting of Documents and Notice of AGM
28th Mar 201110:59 amRNSDirector Dealing
4th Mar 20114:27 pmRNSHolding(s) in Company
28th Feb 20117:00 amRNSFinal Results
15th Feb 20117:00 amRNSNotice of Results
11th Jan 20117:00 amRNSPre-Close Trading Update
16th Dec 20102:06 pmRNSHolding(s) in Company
17th Nov 201010:06 amRNSDirector Dealing
11th Oct 20107:00 amRNSTrading and Business Update
28th Sep 20104:52 pmRNSHolding(s) in Company
28th Sep 20104:50 pmRNSHolding(s) in Company
14th Sep 20107:00 amRNSHolding(s) in Company
27th Aug 20108:51 amRNSDirector Dealing
5th Aug 20107:00 amRNSGrant of Options
2nd Aug 20107:00 amRNSBoard Changes
21st Jul 20107:00 amRNSInterim Results
16th Jul 201010:02 amRNSNotice of Interim Results
12th Jul 20109:18 amRNSHolding(s) in Company
5th Jul 20107:00 amRNSPre-Close Trading Update
18th Jun 20103:08 pmRNSPosting of Annual Report
17th Jun 20103:55 pmRNSHolding(s) in Company
8th Jun 20101:15 pmRNSHolding(s) in Company
4th Jun 201011:43 amRNSResult of General Meeting & Directors' Shareholdng
20th May 20102:05 pmRNSResult of AGM
20th May 20107:00 amRNSAGM Statement
18th May 20107:00 amRNSPlacing and Notice of General Meeting
23rd Apr 20103:34 pmRNSNotice of AGM
15th Apr 20105:07 pmRNSBoard Changes
15th Apr 20104:45 pmRNSLevel of Acceptances and Lapse of Offer
15th Apr 20108:53 amRNSEPT Disclosure
12th Apr 20108:45 amRNSEPT Disclosure
7th Apr 20103:48 pmRNSResponse to Mandatory Offer and Directorate Change
31st Mar 20109:08 amRNSEPT Disclosure
30th Mar 20109:16 amRNSEPT Disclosure
29th Mar 20107:00 amRNSOffer Rejection
25th Mar 20104:23 pmRNSOffer Document Posted
24th Mar 201010:03 amRNSEPT Disclosure
23rd Mar 20103:35 pmRNSHolding in Company
23rd Mar 201011:45 amRNSRule 2.10 Announcement
23rd Mar 20107:00 amRNSRule 2.5 Announcement
18th Feb 20107:00 amRNSFinal Results - Part 2
18th Feb 20107:00 amRNSFinal Results - Part 1
30th Dec 20097:00 amRNSDirector/PDMR Shareholding
24th Dec 20097:01 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.